B · Normal On November 19, Moody's rated Boston Scientific's SR unsecured bonds at A3 with a negative outlook. Global market intelligence 🕐 2026-11-19 17:25 #Global market intelligence #U.S. stock trends 🖼️ Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇ Share 🔗Copy Link 📘Facebook 🐦X (Twitter) 💬WhatsApp 💼LinkedIn 👽Reddit ← Back to Telegraph
Comments